Aeva Q3 revenue $0.8M, GAAP op loss $35.5M; $145M capital raise, production wins

Aeva Technologies, Inc.

2023-Q3 EPS reported -$0.47 revenue$2,701,000

Revenue $0.8M (Q3 2022: $1.4M); GAAP net loss per share $0.15 vs $0.17; non-GAAP net loss per share $0.13 vs $0.14.
Cash, equivalents and marketable securities $233.7M at Sept 30, 2023.
May Mobility selected Aeva as exclusive long-range LiDAR production supplier through 2028, replacing ToF LiDAR.
Nikon awarded multi-year production program for high precision industrial inspection products; Aeva SOP planned late-2024.
Appointed Dr. Stefan Sommer (ex-CEO ZF, VW board) to Board; $145M capital raise ($20M private placement + $125M preferred facility from Adage/Sylebra).

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Aeva Technologies, Inc. reported the third quarter ended September 30, 2023 results: revenue Revenue of $0.8 million in Q3 2023, compared to revenue of $1.4 million in Q3 2022, EPS GAAP net loss per share of $0.15 in Q3 2023, compared to GAAP net loss per share of $0.17 in Q3 2022.

Period: the third quarter ended September 30, 2023
Revenue: Revenue of $0.8 million in Q3 2023, compared to revenue of $1.4 million in Q3 2022
EPS: GAAP net loss per share of $0.15 in Q3 2023, compared to GAAP net loss per share of $0.17 in Q3 2022
Result: reported results

Exact text from the filing

On November 8, 2023, Aeva Technologies, Inc. issued a press release announcing financial results for the third quarter ended September 30, 2023.

View on SEC.gov

8 earnings releases filed in the last 30 days. Browse all earnings releases →

Aeva Technologies, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-23-061055

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.